IBN
Închide

Lista articolelor în limba engleza

Print PDF
Afisarea articolelor: 1-2(2)
2018
1.

Effect of tildrakizumab (MK-3222), a high affinity, selective anti-IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis

. British Journal of Clinical Pharmacology. 2018, nr. , 2302-2292. ISSN 0306-5251. (Cat. )
2011
2.

Influence of different degrees of liver impairment on the pharmacokinetics of clazosentan

. British Journal of Clinical Pharmacology. 2011, nr. , 60-52. ISSN 0306-5251. (Cat. )
 
 

1-2 of 2